(Q34446914)

English

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

2 August 2017

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

object named as

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

hospital-acquired infection

1 reference

based on heuristic

inferred from title

author name string

Dilip Nathwani

1

1 reference

Europe PubMed Central

2 August 2017

Gowri Raman

2

1 reference

Europe PubMed Central

2 August 2017

Katherine Sulham

3

1 reference

Europe PubMed Central

2 August 2017

Meghan Gavaghan

4

1 reference

Europe PubMed Central

2 August 2017

Vandana Menon

5

1 reference

Europe PubMed Central

2 August 2017

publication date

20 October 2014

1 reference

Europe PubMed Central

2 August 2017

Antimicrobial resistance and infection control

1 reference

Europe PubMed Central

2 August 2017

3

1 reference

Europe PubMed Central

2 August 2017

32

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

2 August 2017

https://scigraph.springernature.com/pub.10.1186/2047-2994-3-32

0 references

Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Community acquired infections in older patients admitted to hospital from care homes versus the community: cohort study of microbiology and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: is there a role for antibiotic diversity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Impact of multidrug resistance on Pseudomonas aeruginosa ventilator-associated pneumonia outcome: predictors of early and crude mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Hospital costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Cefepime-resistant Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Pseudomonas aeruginosa: all roads lead to resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Multiresistant Gram-negative infections: a global perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Hospital-acquired infections due to gram-negative bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Has the era of untreatable infections arrived?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Cost of Gram-negative resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Overview of nosocomial infections caused by gram-negative bacilli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

The impact of antimicrobial resistance on health and economic outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

6 July 2018

Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

International study of the prevalence and outcomes of infection in intensive care units

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes.

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care.

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Influx of multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly patients with bacterial bloodstream infection

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Lack of effect of fluoroquinolone resistance on mortality in subjects with Pseudomonas aeruginosa bacteraemia.

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Prevalence and clinical outcomes of episodes of ventilator-associated pneumonia caused by SPM-1-producing and non-producing imipenem-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia

1 reference

https://api.crossref.org/works/10.1186%2F2047-2994-3-32

21 January 2018

Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

27 October 2018

Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

27 October 2018

Update on the appropriate use of meropenem for the treatment of serious bacterial infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

27 October 2018

Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

27 October 2018

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219028

27 October 2018

Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of antibiotic resistance in Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit of Appropriate Empirical Antibiotic Treatment: Thirty-day Mortality and Duration of Hospital Stay

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase-producing Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The consequences of an outbreak of multidrug-resistant Pseudomonas aeruginosa among patients treated for critical leg ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of postoperative pneumonia in the Eole study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality of COPD Patients Infected with Multi-Resistant Pseudomonas aeruginosa: A Case and Control Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost of antibiotic resistance: effect of resistance among Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudmonas aeruginosa on length of hospital stay

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/25371812

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/2047-2994-3-32

1 reference

Europe PubMed Central

2 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34446914&oldid=1955123880"